TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR/Akt signaling (Q34913885)

5 August 2017

TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR/Akt signaling (English)

1 reference

5 August 2017

2

Ann M Bode

1 reference

5 August 2017

12

Zigang Dong

1 reference

5 August 2017

5

Jishuai Zhang

1 reference

5 August 2017

8

Tatyana Zykova

1 reference

5 August 2017

10

Andria L Carper

1 reference

5 August 2017

7

Kanamata Reddy

1 reference

5 August 2017

11

Alyssa K Langfald

1 reference

5 August 2017

Shengqing Li

1

1 reference

5 August 2017

Feng Zhu

3

1 reference

5 August 2017

Kangdong Liu

4

1 reference

5 August 2017

Myoung Ok Kim

6

1 reference

5 August 2017

Wei-ya Ma

9

1 reference

5 August 2017

language of work or name

English

0 references

publication date

23 February 2011

1 reference

5 August 2017

1 reference

5 August 2017

32

1 reference

5 August 2017

5

1 reference

5 August 2017

779-785

1 reference

Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

The role of TRPV1 receptors in pain evoked by noxious thermal and chemical stimuli

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

Akt-dependent and -independent mechanisms of mTOR regulation in cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

Transient receptor potential type vanilloid 1 suppresses skin carcinogenesis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

8 July 2018

The two TORCs and Akt.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

The Akt/mTOR and mitogen-activated protein kinase pathways in lung cancer therapy.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

EGF-ERBB signalling: towards the systems level

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

Epidermal growth factor receptor (EGFR) signaling in cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

PI3K/Akt/mTOR pathway as a target for cancer therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

Expression and characterization of the intracellular vanilloid receptor (TRPV1) in bronchi from patients with chronic cough

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086704

Increased expression of TRPV1 channel in intrinsically aged and photoaged human skin in vivo

8 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR037

AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR037

High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR037

Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR037

New insights into mTOR signaling: mTORC2 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR037

21 January 2018

TRP channels and pain

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21349818

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/CARCIN/BGR037

1 reference

5 August 2017

1 reference

5 August 2017

1 reference